This page lists feature articles on COVID-19 relevant to people working at St Vincent's Health Australia.
All articles listed are open access unless stated otherwise.
Therapy
MoMo30 binds to SARS-CoV-2 Spike variants and blocks infection by SARS-CoV-2 pseudovirus.
Viruses:2024: September 7 Full text
Clinical Practice
Long-term mortality and health-related quality of life with lower versus higher oxygenation targets in intensive care unit patients with COVID-19 and severe hypoxaemia.
Intensive Care Medicine:2024: September 5 Full text
Management of vulnerable patients hospitalized for COVID-19 with remdesivir: a retrospective comparative effectiveness study of mortality in US hospitals .
Clinical Infectious Diseases:2024: October 19 Full text
Advance care planning before and during the COVID-19 pandemic: an observational cohort study of 73 675 patients’ records.
BJGP Open:2024: October 15 Full text
Pathophysiology and Epidemiology
COVID-19 Is a coronary artery disease risk equivalent and exhibits a genetic interaction with ABO blood type.
Ateriosclerosis, Thrombosis and Vascular Biology:2024: October 9 Full text
Clinical and functional assessment of SARS-CoV-2 sequelae among young marines – a panel study.
Lancet Regional Health:2024: October 23 Full text
Incidence and risk of coronavirus disease 2019 hospitalization among unvaccinated children.
Influenza:2024: October 21 Full text
Long Covid
Modeling the burden of long COVID in California with quality adjusted life-years (QALYS).
Scientific Reports:2024: 30 September Full text
Vascular pathogenesis in acute and long COVID: current insights and therapeutic outlook.
Seminars in Thrombosis and Hemostasis:2024: September 30 Full text
Infection Control
SARS-CoV-2 burden on the floor was associated with COVID-19 cases and outbreaks in two acute care hospitals: a prospective cohort study.
Infection Control and Hospital Epidemiology:2024:September 20 Full text
Public Health
Attitudes and behaviours regarding COVID-19 mitigation strategies in Australians with an underlying health condition: a cross-sectional study. AUS
Health Expectations:2024: September 12 Full text
Vaccines
The Platform Trial In COVID-19 Priming and BOOsting (PICOBOO): the immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second booster (fourth dose) in AZD1222 primed individuals aged 50-<70 years old.
Journal of Infection:2024: September 26 Full text
A potent pan-sarbecovirus neutralizing antibody resilient to epitope diversification.
Cell:2024: October 8 Full text
Immunology
A novel SARS-CoV-2 recombinant transmitted from a patient with an acute co-infection.
Lancet Microbe:2024: October 1 Full text
Synergistic evolution: the dynamic adaptation of SARS-CoV-2 and human protective immunity in the real world.
Journal of Infection:2024: October 9 Full text
